Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020.

Format:

Book

Government document

Author/Creator:

United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Investigations and Oversight, author.

Language:

English

Subjects (All):

Drugs--Research--United States.

Drugs.

COVID-19 (Disease)--United States.

COVID-19 (Disease).

COVID-19 (Disease)--Treatment--United States.

COVID-19 (Disease)--Treatment.

Drugs--Research.

United States.

Genre:

Legislative hearings.

Physical Description:

1 online resource (iii, 75 pages) : illustration

Place of Publication:

Washington : U.S. Government Publishing Office, 2021.

Participant:

Hearing witnesses: Dr. Peter Lurie, President, Center for Science in the Public Interest; Dr. James Finigan, Director of the Respiratory Centers of Excellence, National Jewish Health; Dr. Rick L. Stevens, Associate Laboratory Director for Computing, Environment and Life Sciences, Argonne National Laboratory; Dr. Benjamin Rome, Associate Physician, Brigham and Women's Hospital; Postdoctoral Research Fellow, Harvard Medical School.

Notes:

Access ID (govinfo): CHRG-116hhrg40634.

"Serial no. 116-74."

Includes bibliographical references.

Date of hearing: 2020-06-19.

Description based on online resource; title from PDF title page (govinfo, viewed Feb. 3, 2021).

Other Format:

Print version: United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Investigations and Oversight. Repurposing therapeutic drugs for COVID-19

OCLC:

1236207366

Publisher Number:

40-634 (GPO jacket number)